A national collaborative project for the design and method development of precision medicine treatment studies

Testbed Sweden Precision Health Cancer is a national collaborative project for the design and method development of precision medicine treatment studies - for a more equal and sustainable health and cancer care where every patient and resident is offered accurate and individually tailored prevention, diagnosis, treatment, and follow-up based on their unique conditions, such as genetic profile and specific biomarkers.

Cancer is one of our greatest global societal challenges. To meet this, we must create better conditions for research and innovation. Precision health is a very important part of the work to achieve better results for patients and has great potential to improve cancer care along the entire cancer spectrum. If implemented correctly, precision health enables the capacity to prevent, manage and treat cancer fairly and effectively.

Testbed Sweden Precision Health Cancer is an innovation hub for clinical studies that works to facilitate the introduction of more accurate prevention and treatment in cancer care. The initiators are Vision Zero Cancer, Genomic Medicine Sweden (GMS) and SciLifeLab

With funding from Vinnova and the strategic innovation program Swelife, a joint venture by Vinnova, the Swedish Energy Agency and Formas. The project is part of Vinnova's program "Sustainable Precision Health" 2021-2026.

The overall objectives of the innovation environment are to contribute to:

• Increased access to and participation in clinical studies

• Increased precision in prevention and diagnostics

• More effective medical treatments and techniques

• Increased use of existing infrastructure

• Increased internationalisation